Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Vidal-Puig

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Genetics|December 2, 2000
Uncoupling expectationsA J Vidal-Puig
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 14, 2004
Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidationC Lelliott, A J Vidal-Puig
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2001
Mitochondrial uncoupling proteins (UCPs) and obesityV Crowley, A J Vidal-Puig
Biochemical Society Transactions|October 26, 2005
Mouse models of PPAR-gamma deficiency: dissecting PPAR-gamma's role in metabolic homoeostasisS L Gray, E Dalla Nora, A J Vidal-Puig
The Journal of Biological Chemistry|August 8, 1997
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulinA Werman, A Hollenberg, G Solanes, et al.
The Journal of Biological Chemistry|March 29, 2001
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolismG W Cline, A J Vidal-Puig, S Dufour, et al.
The Journal of Clinical Investigation|May 15, 1997
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoidsA J Vidal-Puig, R V Considine, M Jimenez-Liñan, et al.
European Journal of Endocrinology|April 1, 1994
Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenismA J Vidal-Puig, M Muñoz-Torres, E Jódar-Gimeno, et al.
Endocrinology|January 22, 2005
A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoformsR K Semple, A Meirhaeghe, A J Vidal-Puig, et al.
The Journal of Biological Chemistry|April 5, 2000
Energy metabolism in uncoupling protein 3 gene knockout miceA J Vidal-Puig, D Grujic, C Y Zhang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Genetics|December 2, 2000
Uncoupling expectationsA J Vidal-Puig
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 14, 2004
Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidationC Lelliott, A J Vidal-Puig
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2001
Mitochondrial uncoupling proteins (UCPs) and obesityV Crowley, A J Vidal-Puig
Biochemical Society Transactions|October 26, 2005
Mouse models of PPAR-gamma deficiency: dissecting PPAR-gamma's role in metabolic homoeostasisS L Gray, E Dalla Nora, A J Vidal-Puig
The Journal of Biological Chemistry|August 8, 1997
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulinA Werman, A Hollenberg, G Solanes, et al.
The Journal of Biological Chemistry|March 29, 2001
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolismG W Cline, A J Vidal-Puig, S Dufour, et al.
The Journal of Clinical Investigation|May 15, 1997
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoidsA J Vidal-Puig, R V Considine, M Jimenez-Liñan, et al.
European Journal of Endocrinology|April 1, 1994
Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenismA J Vidal-Puig, M Muñoz-Torres, E Jódar-Gimeno, et al.
Endocrinology|January 22, 2005
A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoformsR K Semple, A Meirhaeghe, A J Vidal-Puig, et al.
The Journal of Biological Chemistry|April 5, 2000
Energy metabolism in uncoupling protein 3 gene knockout miceA J Vidal-Puig, D Grujic, C Y Zhang, et al.
Pageof 2